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Editorial on the Research Topic
Preventive and Acute Intervention for Intracranial Atherosclerotic Disease
Intracranial atherosclerotic disease (ICAD) is one of the most important etiologies for acute stroke.
Although ICAD has its own distinct characteristics, acute and preventive endovascular treatment
(EVT) for ICAD has not been well-studied. Recently, several important ICAD endovascular issues
have been developed. First, in themodern era whenmechanical thrombectomy has prevailed, ICAD
is regarded as a relevant reason for the ineffectiveness of mechanical thrombectomy treatment
(1–3). For an acute occlusion by ICAD, different EVT strategies should be elaborated (4). Second,
after the SAMMPRIS trial, preventive EVT for ICAD has been discouraged (5). Instead, most
patients with ICAD have been treated by intensive medical treatment. To advance preventive
EVT for ICAD, it seems to need a breakthrough. This Research Topic discussed the issues for
endovascular management of ICAD.
As the first issue, this Research Topic included (1) the method to identify an acute ICAD-related
large vessel occlusion (ICAD-LVO) and (2) the EVT strategy for ICAD-LVO. Baek et al. described
a unique angiographical way to identify ICAD-LVO before or during EVT—an “occlusion type.”
Among the occlusion types, truncal-type occlusion was considered an ICAD-LVO. Truncal-type
occlusion was significantly associated with non-embolic occlusion (6, 7). Furthermore, stent
retriever thrombectomy was ineffective for the truncal-type occlusion, which needed different
types of endovascular modalities other than mechanical thrombectomy devices. In this Research
Topic, detailed methodology to assess occlusion type was explained. This review also discussed
a few concerns with regard to determining occlusion type. Considering that we do not have
reliable information about the etiology of acute LVO before or in the early EVT period, this
review might be helpful to set up an optimal EVT strategy. Lee et al. compared occlusion type
with the classical definition of ICAD-LVO. The truncal-type occlusion determined by computed
tomography angiography was best correlated with fixed focal stenosis in the posterior circulation.
This finding is well-understood by the fact that occlusion type in the posterior circulation was less
influenced by the degree of pial collateral flow or embolus size, as described in the review by Baek
et al. Based on reports by Baek et al. and Lee et al., it seems that those two angiographical surrogate
markers for ICAD-LVO should be complementary for a better definition of ICAD-LVO. Besides
the angiographical method to identify ICAD-LVO, Bang et al. focused on neuro-imaging features
that can aid identification of ICAD-LVO and that should be considered when performing EVT
for ICAD-LVO. ICAD-LVO may have different anatomic, hemodynamic, and pathophysiologic
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features on neuroimaging compared to embolic occlusion.
In neuroimaging, ICAD-LVO is associated with intracranial
plaques, erythrocyte-poor thrombi, more severe arterial
tortuosity with calcification, perforator-bearing segments,
and preexisting collaterals, which should be considered when
treating ICAD-LVO endovascularly. Even for ICAD-LVO, a
stent retriever is still commonly used as the first-line modality.
However, we do not exactly know how the stent retriever acts
in ICAD-LVO. Lee et al. retrospectively compared outcomes
of stent retriever thrombectomy between ICAD-LVO and
embolic occlusion. The first-line stent retriever thrombectomy
in ICAD-LVO could give a similar immediate successful
reperfusion rate to embolic occlusion, although ICAD-LVO
finally needed more ICAD-specific modalities such as balloon
angioplasty, stenting, or intra-arterial tirofiban infusion. From
previous studies, we already know that ICAD-LVO commonly
needs the ICAD-specific modalities to achieve a successful
recanalization (8–10). This can be also observed in the report
by Baek et al.. They compared procedural and clinical outcomes
between ICAD-LVO and embolic occlusion in the posterior
circulation. Conventional mechanical thrombectomy was
less effective in ICAD-LVO. With the use of ICAD-specific
modalities, they could get a comparable successful recanalization
rate, procedural time, and favorable outcomes for those with
embolic occlusions. Such an endovascular strategy based on
ICAD-specific modalities was well-summarized in the review
by Park et al.. They proposed ways to identify ICAD-LVO,
optimal choice of the front-line mechanical thrombectomy
modality, and rescue strategy with ICAD-specific modalities
after mechanical thrombectomy failure. With all these articles,
in ICAD-LVO, successful recanalization could be achieved and
time to recanalization could be shorter, which eventually led to
better patient clinical outcomes.
As the second issue, this Research Topic included several
subtopics on preventive EVT for ICAD. Luo et al. described
EVT for ICAD. As we already know, intracranial stenting
for secondary prevention of stroke associated with ICAD was
not favorable in most clinical situations. However, authors
expected that EVT with improved devices and techniques
for carefully selected ICAD patients might be beneficial. In
fact, Du et al. reported a case series of medically intractable
ICAD patients who underwent stenting with Neuroform EZ,
a self-expandable stent more easily handled than Wingspan.
According to their report, stenting with Neuroform EZ was
completely feasible in all patients. Luo et al. also pointed
out that perforators around an atherosclerotic lesion is an
important factor affecting outcomes of EVT for ICAD. In
this Research Topic, Nordmeyer et al. reported that balloon
angioplasty with/without stenting was harmful in perforator-
bearing atherosclerotic lesions. In particular, periprocedural and
follow-up strokes were significantly more frequent in ICAD in
the posterior circulation, of which all periprocedural events were
perforator strokes.
Differentiation of ICAD from other etiologies (such as arterial
dissection, etc.) is also an important issue. Interestingly, Gao
et al. reported the case of an acute stroke with an arterial
lesion that was evaluated by optical coherence tomography.
For their case with basilar artery stenosis, optical coherence
tomography gave definite information about arterial dissection
and this might be helpful to diagnose ICAD when angiography
is ambiguous. In ICAD, vessel wall magnetic resonance imaging
can be also helpful. Lee et al. systemically reviewed previous
studies of vessel wall magnetic resonance imaging for ICAD.
Some imaging findings, such as plaque enhancement, positive
remodeling, and plaque surface irregularity were associated with
stroke events in patients with ICAD. This finding could be
helpful for estimating plaque vulnerability in decision making for
ICAD management.
In conclusion, ICAD is obviously a big hurdle in EVT for
LVO. For preventive EVT for ICAD, it is a situation that needs
successful clinical trials. However, EVT for ICAD will be most
likely developed by optimal endovascular strategy and more
advanced endovascular devices and techniques. This Research
Topic provides an insight into the future prospects of EVT
for ICAD.
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